JP2015506999A5 - - Google Patents

Download PDF

Info

Publication number
JP2015506999A5
JP2015506999A5 JP2014557019A JP2014557019A JP2015506999A5 JP 2015506999 A5 JP2015506999 A5 JP 2015506999A5 JP 2014557019 A JP2014557019 A JP 2014557019A JP 2014557019 A JP2014557019 A JP 2014557019A JP 2015506999 A5 JP2015506999 A5 JP 2015506999A5
Authority
JP
Japan
Prior art keywords
budesonide
excipient
tablet
matrix
amphiphilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014557019A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015506999A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/052838 external-priority patent/WO2013120881A1/en
Publication of JP2015506999A publication Critical patent/JP2015506999A/ja
Publication of JP2015506999A5 publication Critical patent/JP2015506999A5/ja
Pending legal-status Critical Current

Links

JP2014557019A 2012-02-13 2013-02-13 少なくとも1つの炎症性要素を呈する腸管疾患を治療するための方法 Pending JP2015506999A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261598308P 2012-02-13 2012-02-13
US61/598,308 2012-02-13
PCT/EP2013/052838 WO2013120881A1 (en) 2012-02-13 2013-02-13 Method for treating intestinal diseases presenting at least one inflammatory component

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017138019A Division JP6472063B2 (ja) 2012-02-13 2017-07-14 少なくとも1つの炎症性要素を呈する腸管疾患を治療するための方法

Publications (2)

Publication Number Publication Date
JP2015506999A JP2015506999A (ja) 2015-03-05
JP2015506999A5 true JP2015506999A5 (enExample) 2015-12-17

Family

ID=47722264

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014557019A Pending JP2015506999A (ja) 2012-02-13 2013-02-13 少なくとも1つの炎症性要素を呈する腸管疾患を治療するための方法
JP2017138019A Expired - Fee Related JP6472063B2 (ja) 2012-02-13 2017-07-14 少なくとも1つの炎症性要素を呈する腸管疾患を治療するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017138019A Expired - Fee Related JP6472063B2 (ja) 2012-02-13 2017-07-14 少なくとも1つの炎症性要素を呈する腸管疾患を治療するための方法

Country Status (15)

Country Link
US (5) US20150017239A1 (enExample)
EP (1) EP2814495B1 (enExample)
JP (2) JP2015506999A (enExample)
CN (2) CN110693890A (enExample)
AU (1) AU2013220464A1 (enExample)
BR (1) BR112014020095A8 (enExample)
CA (1) CA2864065A1 (enExample)
DK (1) DK2814495T3 (enExample)
ES (1) ES2882880T3 (enExample)
HK (1) HK1204927A1 (enExample)
IL (1) IL234054A0 (enExample)
IN (1) IN2014DN06662A (enExample)
PT (1) PT2814495T (enExample)
RU (1) RU2649807C2 (enExample)
WO (1) WO2013120881A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2974864B1 (fr) * 2011-05-04 2016-05-27 Snecma Rotor de turbomachine avec moyen de retenue axiale des aubes
US10375513B2 (en) * 2013-05-01 2019-08-06 3 Electric Sheep Pty Ltd Event notification systems and methods
WO2015071812A1 (en) * 2013-11-18 2015-05-21 Wockhardt Limited Solid oral modified-release composition comprising budesonide or salt thereof
US10327034B2 (en) * 2014-03-27 2019-06-18 Tvu Networks Corporation Methods, apparatus and systems for exchange of video content
WO2019092614A1 (en) * 2017-11-10 2019-05-16 Cosmo Technologies Ltd. Oral rifamycin sv compositions
EP3501496A1 (en) * 2017-12-22 2019-06-26 Cosmo Technologies Ltd. Liquid delivery composition
CN110585164A (zh) * 2019-10-08 2019-12-20 苏州弘森药业股份有限公司 一种艾司奥美拉唑镁碳酸氢钠胶囊的制作方法
CN119185229A (zh) * 2023-06-26 2024-12-27 湖南慧泽生物医药科技有限公司 一种含皮质类固醇的药物组合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2274943A1 (en) * 1998-06-17 1999-12-17 Stephen L. Wolman Compositions for the treatment and prevention of inflammatory diseases of the gastrointestinal tract and methods and uses thereof
DE19849737A1 (de) * 1998-10-28 2000-05-04 Falk Pharma Gmbh Kombinationsmittel zur Behandlung entzündlicher Darmerkrankungen
US8895064B2 (en) * 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
RU2246293C2 (ru) 1999-06-14 2005-02-20 Космо С.П.А. Фармацевтические композиции для перорального введения с регулируемым высвобождением активного ингредиента и маскируемым вкусом
WO2004087109A1 (ja) * 2003-03-27 2004-10-14 Hisamitsu Pharmaceutical Co., Inc. 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
AU2006348180A1 (en) * 2006-09-13 2008-03-20 Warner Chilcott Company, Llc Methods of treatment for ulcerative colitis
JP2010529197A (ja) * 2007-06-13 2010-08-26 ジェイ プラーヴダ, 酸化的ストレス関連疾患の治療および診断のための材料および方法
EP2298321A1 (en) * 2009-08-26 2011-03-23 Nordic Pharma Novel pharmaceutical compositions for treating IBD

Similar Documents

Publication Publication Date Title
JP2015506999A5 (enExample)
JP2014111603A5 (enExample)
JP2019508789A5 (enExample)
JP2016518337A5 (enExample)
JP2015533163A5 (enExample)
JP2018503687A5 (enExample)
JP2013523758A5 (enExample)
JP2019528267A5 (enExample)
JP2015516452A5 (enExample)
CL2008000965A1 (es) Composicion farmaceutica que comprende un agente antiinflamatorio no esteroideo y un analgesico opiaceo, y su uso para el tratamiento del dolor.
JP2014529579A5 (enExample)
JP2015516450A5 (enExample)
JP2015516449A5 (enExample)
CL2015001457A1 (es) Composición simbiótica que comprende una cepa de bifidobacterium probiótica y un componente oligosacárido que comprende arabino xilo-oligosacáridos, útil para inhibir infección por patógenos en el colon; y composición alimenticia que la comprende.
CN302519705S (zh) 手术床用的操作单元
JP2013503876A5 (enExample)
CN302287219S (zh) 糖果盘
CN302222400S (zh) 钛涂层修补网(钛乐贝拉)
CN302520406S (zh) 落地灯
CN302351303S (zh) 摄像头
CN302425485S (zh) 药片(bys)
CN302351807S (zh) 斜面瘦身器
CN302161235S (zh) 网椅(hlc2319)
CN302233587S (zh) 医疗装置用操作面板
CN302374136S (zh) 心电图机